Abstract: Phthalocyanine compounds of Formula (1) have utility as colorants in inks for ink-jet printing, where Formula (1) represents: ##STR1## in which: M represents a metal or H;Pc represents a phthalocyanine nucleus; andR.sup.1 represents H or --(CH.sub.2).sub.n R.sup.3 ; R.sup.2 represents(CH.sub.2).sub.n R.sup.3 ; or R.sup.1 and R.sup.2 together with the nitrogen atom to which they are attached represent a 5 or 6-membered ring; where:n is independently an integer from 1 to 30; andR.sup.3 is independently a group selected from hydroxy, sulpho, cyano, --SR.sup.4, --CO.sub.2 R.sup.5, --PO.sub.3 H.sub.2 and --NR.sup.6 R.sup.7 ; where:R.sup.4, R.sup.5, R.sup.6 and R.sup.7 independently represent H, C.sub.1-30 alkyl optionally substituted by one or more groups selected from hydroxy, mercapto, sulpho, carboxy, cyano and --PO.sub.3 H.sub.2 ;v is the valence of Pc divided by the valence of M;x is from 1.2 to 3.8;y is from 0.1 to 2.7;z is from 0.1 to 2.7; andx, y and z satisfy 2.ltoreq.x+y+z.ltoreq.4.

Abstract: The capacity of a plant to produce fatty acids is modulated by controlling the expression of a gene specifying the acetyl CoA carboxylase biotin carboxyl carrier protein. Modulation may comprise increasing the expression of the gene by insertion of additional copies into the genome or inhibiting expression by insertion of an antisense or cosuppression vector directed against the endogenous gene.

Abstract: Antimicrobial proteins are isolated from seeds of Impatiens, and show a wide range of antifungal activity and some antibacterial activity. DNA encoding the proteins is isolated and incorporated into vectors. Plants transformed with this DNA are produced. The invention further provides a method of expressing polyproteins in transgenic plants using DNA constructs based on the structure of the gene encoding the Impatiens antimicrobial proteins.

Abstract: Compounds of formula I: ##STR1## wherein Q.sup.1, Q.sup.2, Q.sup.3, Q.sup.4, and Q.sup.5 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of SP and NKA are useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.

Abstract: A method is presented for spray-drying whole microorganisms of Fusarium lateritium, Methylophilus methylotrophus, and Pseudomonas putida under conditions that the activity of cyanide hydratase, amidase and D-2-haloalkanoic acid halidohydrolase respectively are retained.

Abstract: The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxy-carbonyl)amino-1-methylindol-3-yl-methyl]-3-methox ybenzoyl]-2-methyl-benzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.

Abstract: A process for the preparation of 2-hydroxy-6-trifluoromethylpyridine which comprises reacting 2-fluoro-6-trifluomethylpyridine or a mixture of 2-fluoro-6-trifluoromethylpyridine and 2-chloro-6-trifluoromethylpyridine with an alkali metal hydroxide at a temperature of from 50.degree. C. to 160.degree. C. and acidifying the product so formed.

Abstract: A composition of matter is provided in which a phosphonic acid or phosphonic acid ester group is linked through a thioether residue to a silicon atom which is further covalently bonded to a solid inorganic support. The compositions can be employed to selectively separate metal ions having high cationic charge from a solution containing lower-charged cations, and also to selectively separate highly charged cations having a relatively high charge density from cations having the same charge, but a lower charge density.

Abstract: Plasmids which comprise: (1) an origin of replication; (2) an additional sequence required for plasmid replication or preferably a gene giving a selective advantage; and (3) two expression cassettes each of which are located between (1) and (2) but are separated by (1) and (2) from each other; and which are free from inverted repeat sequences (other than in (3)) are highly persistent though successive generations of microbes containing them.

Abstract: Polyurea microcapsules particularly suitable for foliar application are prepared by an interfacial polymerization process in which the polyurea is formed from an aromatic diisocyanate and optionally an aromatic polyisocyanate having 3 or more isocyanate groups, in a weight ratio (when both types of isocyanate are present) of polyisocyanate:diisocyanate of from about 1:100 to about 1:1.5, and in which the microcapsules are produced having an average particle size of from about 1 to about 5 microns.As compared to conventional liquid (e.g., emulsifiable concentrate) compositions of pesticides, the microcapsules can provide safer handling and higher loading of active ingredients, while providing substantially equivalent biological activity to the liquid compositions.

Abstract: Process for forming a selectively colored polymeric layer, or a three-dimensional article made of polymeric layers, wherein a photocurable, photocolorable composition is irradiated with a low dose of light to cure and a different, preferably higher, dose of light to color. The process is particularly useful for preparing selectively colored ornamental and industrial articles and models of plant and animal parts, especially medical models.

Abstract: A dispersant which is a phosphate ester of a block copolymer of formula MeO(C.sub.2 H.sub.4 O).sub.m (PES).sub.n --H wherein PES is derived from .epsilon.-caprolactone, m is 5-60, n is 2-30 and the MW of MeO(C.sub.2 H.sub.4 O).sub.m is greater than the MW of (PES).sub.n and use in aqueous-based paints and printing inks.

Abstract: The present invention provides a process for the preparation of 1,1-difluoro-1,4-dichlorobutane by reacting 1,1,1,4-tetrachlorobutane or 1,1,4-trichlorobut-1-ene with hydrogen fluoride in the vapor phase.

Abstract: Compounds of formula I ##STR1## wherein G, J, L, M, m and D have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of neurokinin A and useful for the treatment of asthma, etc. Also disclosed are pharmaceutical compositions, processes for preparing the compounds of formula I and intermediates.

Abstract: The invention relates to azolobenzazepine derivatives of formula (I), wherein: X is O or S; R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are independently hydrogen, perfluorolower-alkyl, halogen, nitro or cyano; and C together with the carbon atoms to which it is attached forms a 5-membered aromatic heterocycle selected from the group consisting of a pyrazol and triazole, to pharmaceutical compositions containing them and to methods for the treatment of neurological disorders utilizing them.

Abstract: A fungicidal compound of formula (I): or a stereoisomer thereof, wherein A is CH or N, B is OCH.sub.3 or NHCH.sub.3, E is --NR.sup.1 --C(CH.sub.3).dbd.N-- or --N.dbd.C(CH.sub.3)--NR.sup.1 --, R.sup.1 is H, C.sub.1-4 alkyl, C.sub.2-4 alkenyl, C.sub.2-4 alkynyl or optionally substitute benzyl, R.sup.2 is H, C.sub.1-4 alkyl, halo(C.sub.1-4)alkyl, C.sub.3-6 cycloalkyl, C.sub.2-4 alkenyl or C.sub.2-4 alkynyl, and R.sup.3 is optionally substituted aryl or optionally substituted heterocyclyl.

Abstract: A polymeric material comprising at least first and second polymer parts, which first part has a number average molecular weight higher than that of the second part and which first and second polymer parts each comprise a respective polymer part derived from at least one ethylenically unsaturated monomer, is prepared by a process which comprises the steps of (1) preparing, by aqueous suspension polymerisation the first, higher molecular weight polymer part in the presence of a free radical initiator, but in the absence of a chain transfer agent to form a suspension of the first, higher molecular weight part and thereafter (2) preparing by aqueous suspension polymerisation the second, lower molecular weight part, which preparation step (2) is carried out in the presence of the suspension of the first, higher molecular weight part, a free radical initiator and a catalytic chain transfer agent (CCTA).

Abstract: An aqueous agrochemical concentrate formulation comprises a) an agrochemical electrolyte such as salts of glyphosate, fomesafen, glufosinate, paraquat or bentazone, b) an alkoxylated adjuvant, c) an alkylglycoside and d) a co-surfactant which interacts with the alkylglycoside to form a structured aqueous system. Preferred co-surfactants are:- (i) a linear or branched chain aliphatic or aromatic alcohol, (ii) an alcohol or ester or alkyl phenol alkoxylate having a degree of alkoxylation lower than that of the alkoxylated adjuvant present in the formulation as component (b), (iii) a glyceryl alkyl or alkenyl ester and (iv) a sorbitan alkyl or alkenyl ester.